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Some time ago Schultz and his colleagues (Schultz
et al., 1972; 1976) demonstrated that myelo-
peroxidase, when injected daily into tumour-bearing
mice in conjunction with thio-TEPA, causes a
significant decrease in the rate of tumour growth.
Neither myeloperoxidase nor thio-TEPA alone
appeared to be effective, and retardation in tumour
growth was only observed as long as treatment was
continued.
In vitro, myeloperoxidase in the presence of
hydrogen peroxide and a halide ion exerts a potent
cytotoxic activity against a variety of cell types.
These include bacteria (Klebanoff & Luebke, 1965;
Klebanoff et al., 1966, 1970; Klebanoff, 1967, 1968;
McRipley & Sbarra, 1967), fungi (Lehrer, 1969;
Lehrer & Jan, 1970; Diamond et al., 1972; Howard,
1973), viruses (Belding et al., 1970), and a variety
of mammalian cells (Klebanoff & Smith, 1970;
Edelson & Cohn, 1973; Clark et al., 1975;
Klebanoff & Clark, 1975; Clark et al., 1976; Clark
& Klebanoff, 1977). Presently available evidence
suggests that the toxic activity of myeloperoxidase
involves the generation of oxygen radicals or
similar highly reactive species (Klebanoff & Clark,
1978). Other peroxidases such as lactoperoxidase
and horseradish peroxidase have similar cytotoxic
properties (Oram and Reiter, 1966; Jacques et al.,
1975; Reiter, 1978). Again, in vitro this activity
appears to be non-specific and affects prokaryotic
as well as eukaryotic cells.
Schultz's experiments, however, indicated that in
vivo the myeloperoxidase, at least in conjunction
with thio-TEPA, may have a specific antitumour
activity rather than a non-specific toxic activity.
Obviously, if the toxic activity of a peroxidase
could be specifically directed toward cancer tissues
in vivo, then such an enzyme could be of chemo-
therapeutic value. We therefore decided to further
evaluate the effect that peroxidases might have on
tumour-bearing animals.
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In order to construct an enzyme system that
would function as the peroxidase-H202-halide
system in vivo we immobilized the peroxidase
together with a hydrogen peroxide producing
enzyme onto small solid beads. This would assure
that hydrogen peroxide is continually produced in
the immediate vicinity of the peroxidase. Since
chloride ions are ubiquitiously distributed, no
special action was considered necessary to assure
the availability of halide ions. Thus, a 20g CNBr-
activated Sepharose-4 was suspended in 50ml 0.1 M
phosphate buffer, pH 7.0, containing 1% lysine,
and the suspension was stirred overnight. The gel
was then thoroughly washed with water and stirred
for 10h in 5% NaCl. The gel was again washed
and then filtered over a Buchner funnel. The
packed gel was resuspended in 20ml buffer and
2ml 50% glutaraldehyde was added. After 1 h
stirring at room temp. the gel was washed
thoroughly with buffer. The gel was then added to
a solution containing 20mg horseradish peroxidase
(Sigma, type VI) and 4.5ml glucose oxidase (A.
niger; Sigma, type V, 1000 Uml-1). The mixture
was gently shaken overnight at 4°C and the
immobilized enzymes were separated from any
unbound enzymes by the procedure described by
Mosbach and Mattiassen (1976). The gel was then
lyophilized to dryness and the dry powder was
stored at -20° until use.
Our first experiments were done using Novikoff
hepatoma bearing rats. Three week old Sprague-
Dawley rats were inoculated i.p. with 0.5ml of a
Novikoff hepatoma cell suspension and the tumour
was allowed to develop for 5 days. Each rat was
then injected i.p. with 5mg of the immobilized
enzymes, suspended in 1 ml PBS containing 0.1%
glucose. This treatment was repeated for 5
consecutive days. All 10 control animals died within
15 days after tumour inoculation. Of the 10 treated
animals 9 were still alive 15 days after tumour
inoculation and 6 were still alive after 40 days (one
animal was sacrificed on the 15th day for a
pathological evaluation). A histopathological
examination of the contents of the sacrificed rat
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indicated the presence of islands of necrotic tumour
cells encapsulated by fibroblasts. Necrosis of the
tumour appeared to be total and secondary fibro-
plasia was apparent. The results of similar
experiments, using different doses of the
immobilized enzymes, are illustrated in Figure 1
and Table I. Administration of a gel containing
only glucose oxidase (the peroxidase being omitted
in the immobilization procedure) was without any
effect.
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Figure 1 Survival profiles of Novikoff hepatoma
bearing rats after treatment with immobilized glucose
oxidase-horseradish peroxidase. I.p. injections of the
enzymes were started on the day following tumour
injection and continued daily for 9 days. Daily
injections consisted of the indicated amount of the
immobilized enzymes suspended in 1 ml PBS,
containing 0.1% glucose. (x) 1.25mgd'-; (A)
2.5mgd-1; (U) lOmgd-'. Control animals (S)
received buffer only. Each group consisted of 6 rats
and 24 rats were used as controls.
Table I Survival rate of Novikoff hepatoma-bearing rats
following treatment with various doses of immobilized
glucose oxidase and horseradish peroxidase. All animals
received a total of 9 daily i.p. injections of the indicated
amount of immobilized enzyme starting the day following
i.p. injection of tumour cells.
Number of Dose per Number ofsurvivors
animals injection on day 40following
in group (mgkg 1) tumour injection
6 160 4
6 80 5
6 40 3
6 20 2
6 10 3
6 5 2
6 2.5 2
6 1.25 4
24 None oa
a22 animals were dead on day 14 and all animals were
dead on day 21 following tumour injection.
Injection of a mixture of the glucose oxidase and
horseradish peroxidase in soluble form was effective
when injections were given at shorter intervals
(every 12h) and for longer periods of time.
However, even under those conditions the results
were much less dramatic than those observed with
an equivalent amount of the immobilized enzymes.
This may in part be due to the fairly rapid
degradation and clearance of foreign proteins in
vivo.
A necropsy of several of the rats treated with the
immobilized peroxidases revealed that the toxic
action was very specifically directed against the
tumour cells; cells from normal tissues immediately
adjacent to the necrotic tumour were unaffected
and no damage to any normal cells could be
detected. This suggested that the peroxidase system
may have a low toxicity level for normal tissues.
To verify this point normal, healthy rats were
injected i.p. with large amounts of immobilized
peroxidase. Groups of 10 rats each were given a
single dose of 62.5, 125, 250, 500 and 1000mgkg-1
of the immobilized peroxidase. No toxic effects
were observed as a result of these injections and
none of the animals died over the test period (21
days). A similar experiment, using amounts up to
600mgkg-' per rat, was done several times with
identical results. These data confirm that the
toxicity of the peroxidase system in vivo is quite
specifically directed toward cancer cells.
We further tested the effectiveness of the im-
mobilized peroxidase system against the B16 mouse
melanoma. Injections of 2.5, 5 and 10mg of
immobilized peroxidase were given i.p. to groups of
10 mice, starting the day following injection of the
tumour cells, and treatment was continued daily for
9 days. The results in terms of survival time were
less dramatic than those observed with the
Novikoff hepatoma, as illustrated in Figure 2.
Finally, some experiments were done with
DMBA induced rat mammary tumours. Female
rats, 50 days old, were given 20mg DMBA in
1.0ml sesame oil intragastrically. Mammary
tumours developed from 1 to 6 months later.
Histology on biopsies of these tumours revealed the
development of 9 epithelial papillary adenomas and
6 fibroblastic adenomas. Seven of the animals with
epithelial tumours and 5 animals with fibroblastic
tumours received daily injections of 5mg horse-
radish peroxidase and glucose oxidase, immobilized
onto polylysine and suspended in 1 ml PBS, for 6
consecutive days directly into the mammary
tumours. The size of the tumours was then
monitored for a period of up to 6 months following
treatment. One of the epithelial tumours underwent
a total regression within 6 weeks, but reappeared at
the same site 6 months later. The other epithelial
tumours either decreased in size or remained theANTITUMOUR ACTIVITY OF PEROXIDASES 745
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Figure 2 Survival profiles of B-16 melanoma bearing
mice after treatment with immobilized glucose oxidase-
horseradish peroxidase. Tumour as well as enzymes
were injected i.p. Enzyme treatments were started on
the day following tumour injection as described in
Figure 1. Control group: 40 mice, test groups: 10 mice
each. (0) controls; (A) 2.5mgd-1; (A) 5mgd-1; (M)
10mgd-'.
same. The fibroblastic tumours, however, increased
rapidly in size, perhaps even somewhat faster than
the control tumour. We conclude that under the
conditions of the experiment the peroxidase caused
a definite cytostasis and sometimes a regression of
the epithelial tumours, but the enzyme is without
effect or might even stimulate the growth of the
fibroblastic tumours. Since both types of tumours
are benign, no information is available concerning
metastasis.
The most exciting and surprising observation in
this series of experiments was the high specificity of
the toxic activity of the peroxidases toward tumour
cells and the very low toxicity of the enzymes
toward normal tissues. This was unexpected in view
of the toxic action of the enzyme system in vitro,
which appears to have little or no specificity for
any given cell type. The high specificity in vivo of
the peroxidase system could be a definite advantage
if this system can be developed into a chemo-
therapeutic agent.
It is further of interest to note the total lack of a
relationship between dose and number of surviving
animals. The results in Table I clearly indicate that
the lowest dose, 1.25mgkg-1, is as effective as any
of the higher doses. Yet none of the doses used
yielded 100% survival. A possible explanation for
these observations is that the tumouricidal activity
of the immobilized enzyme system is fully depen-
dent on the presence of one or more endogenous
entities, which are present in insufficient amounts
to yield 100% survival. The participation of such
entities could also help to explain the very high
specificity of the peroxidase system for tumour cells
in vivo, since no specificity is found in vitro.
It is obviously extremely important to elucidate
the basis for the in vivo specificity of the peroxidase
system and to identify the endogenous factor(s) that
direct the toxic activity of the enzyme specifically
toward the tumour cells or that protect normal cells
from the toxic activity. Such information could
prove to be useful not only in understanding why
certain tumours are more responsive to the action
of peroxidases than others, but also in our
approach to design new and more specific
anticancer agents.
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